Skip to main content
SpringerLink
Log in

Assessment of in vivo natural antitumor resistance and lymphocyte

Migration in mice: Comparison of 125I-iododeoxyuridine with 111Indium-oxine and 51chromium as cell labels

  • Original Articles
  • Published:
Cancer Immunology, Immunotherapy Aims and scope Submit manuscript

Summary

Clearance of IV-injected tumor cells has been correlated with levels of natural killer (NK) cell activity in recipient animals. Studies of in vivo tumor cell clearance strongly suggest a relationship between levels of NK cell activity and antitumor or antimetastatic effector function. This study outlines the applicability of three radiolabels, [125I]iododeoxyuridine, ([125I]dUrd), indium-111-oxine chelate ([111In]Ox), and chromium-51 (51Cr), to studies of tumor cell clearance in vivo. The suitability of these labels for analysis of the in vivo migration patterns of normal lymphocytes or thymus-derived T cells cultivated in vitro (CTC) is also discussed. The results indicate that [111In]Ox and 51Cr compare favorably with the more widely used [125]dUrd as radiolabels for the assessment of IV-injected tumor cell clearance from the lungs of mice. The rates of clearance of both [111In]Ox and 51Cr, like that for [125I]dUrd, correlate closely with levels of NK-cell activity of the host. Further studies with [111In]Ox reveal that treatment of recipients with anti-asialo GM1 serum, a regimen known to suppress NK-cell activity, demonstrates the appropriate reduction in isotope clearance from the lungs after NK suppression. However, clearance data obtained by monitoring levels of radioactivity in the liver after IV injection must be viewed cautiously, since the same cells labeled with [111In]Ox and [125I]dUrd had a different pattern of clearance from the liver. The same inconsistencies in clearance were observed when [111In]Ox and [125I]dUrd were injected intrafootpad (i.f.p.). Similar effects were observed when [111In]Ox or 51Cr was applied to studies of CTC migration. Levels of [111In]Ox and 51Cr remained high in the liver after IV injection, while [125I]dUrd was rapidly cleared. Normal spleen or thymic lymphocytes exhibited the expected homing to the spleen after labeling with [111In]Ox, indicating a suitability of this label for migration studies, except possibly in the liver. These results with CTC and normal lymphocytes should be considered during the formulation of immunotherapy protocols based on cell migration data, since the choice of radiolabel can result in widely divergent levels of radioactivity accumulated in some organs, and may not provide an accurate representation of the presence of viable, intact, or functional cells.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Bainbridge DR, Brent L, Gowland G (1966) Distribution of allogeneic 51Cr-labeled lymph node cells in mice. Transplantation 4:138–153

    Google Scholar 

  2. Cahill RNP, Frost H, Trika Z (1976) The effects of antigen on the migration of recirculation lymphocytes through single lymph nodes. J Exp Med 143:870–888

    Google Scholar 

  3. Cerottini J-C, Brunner KT (1974) Cell-mediated cytotoxicity, allograft rejection, and tumor immunity. Adv Immunol 18:67–132

    Google Scholar 

  4. Dunn TB, Potter MJ (1957) A transplantable mast-cell neoplasm in the mouse. J Natl Cancer Inst 18:587–595

    Google Scholar 

  5. Ferluga J, Allison AC, Thakur ML (1979) The use of indium-111 for studies of cytotoxicity mediated by lymphocytes or by antibodies and complement. J Clin Lab Immunol 1:339–342

    Google Scholar 

  6. Fidler I (1970) Metastasis: Quantitative analysis of distribution and fate of tumor emboli labeled with IUDR-125. J Natl Cancer Inst 45:775–782

    Google Scholar 

  7. Frost H, Frost P, Wilcox C, Thrall J (1979) Lymph node scanning in sheep with 111In-labeled lymphocytes. Intl J Nucl Med Biol 6:60–67

    Google Scholar 

  8. Frost P, Frost H (1979) Recirculation of lymphocytes and the use of Indium-111. J Nucl Med 20:169–170

    Google Scholar 

  9. Frost P, Wiltrout R, Maciorowski Z, Rose NR (1977) An isotope release cytotoxicity assay applicable to human tumors: The use of 111Indium. Oncology 34:102–105

    Google Scholar 

  10. Frost P, Smith J, Frost H (1978) The radiolabeling of lymphocytes and tumor cells with 111Indium. Proc Soc Exp Biol Med 157:61–65

    Google Scholar 

  11. Frost P, Wiltrout RH, Smith J, Frost H, Pontes E (1981) Immunobiologic uses of the indium-111-oxine chelate. In: Thakur ML, Gottschalk A (eds) Indium-111 labeled neutrophils, platelets, and lymphocytes. Trivirium, New York, pp 191–199

    Google Scholar 

  12. Gorelik E, Herberman RB (1981) Radioisotope assay for evaluation of in vivo natural cell-mediated resistance of mice to local transplantation of tumor cells. Int J Cancer 27:709–720

    Google Scholar 

  13. Gorelik E, Wiltrout R, Okumura K, Habu S, Herberman RB (1982) Role of NK cells in the control of metastatic spread and growth of tumor cells in mice. Int J Cancer 30:107–112

    Google Scholar 

  14. Haller O, Hansson M, Kiessling R, Wigzell H (1977) Role of non-conventional natural killer cell resistance against syngeneic tumor cells in vivo. Nature 270:609–611

    Google Scholar 

  15. Herberman RB (1981) Assessment of cytolysis of tumor cells by release of [125I]dUrd iododeoxyuridine. In: Adams DO, Edelson P, Koren H (eds) Methods for studying mononuclear phagocytes. Academic Press, New York, pp 801–812

    Google Scholar 

  16. Herberman RB (ed) (1982) NK Cells and other natural effector cells. Academic Press, New York

    Google Scholar 

  17. Herberman R, Nunn M, Lavrin D (1975a) Natural cytotoxic reactivity of mouse lymphoid cells against syngeneic and allogeneic tumors. I. Distribution of reactivity and specificity. Int J Cancer 16:216–229

    Google Scholar 

  18. Herberman RB, Nunn ME, Holden HT, Lavrin DH (1975b) Natural cytotoxic reactivity of mouse lymphoid cells against syngeneic and allogeneic tumors. II. Characterization of effector cells. Int J Cancer 16:230–239

    Google Scholar 

  19. Herberman RB, Djeu JY, Kay HD, Ortaldo JR, Riccardi C, Bonnard GD, Holden HT, Fagnani R, Santoni A, Puccetti P (1979) Natural killer cells: Characteristics and regulation of activity. Immunol Rev 44:43–70

    Google Scholar 

  20. Hersey P (1971) Separation and 51chromium labeling of human lymphocytes with in vivo studies of survival and migration. Blood 38:360–371

    Google Scholar 

  21. Hofer K, Prensky W, Hughes W (1969) Death and metastatic distribution of tumor cells in mice monitoring with 125I-iododeoxyuridine. J Natl Cancer Inst 43:763–769

    Google Scholar 

  22. Issekutz T, Chin W, Hay JB (1980) Measurement of lymphocyte traffic with indium-111. Clin Exp Immunol 39:215–221

    Google Scholar 

  23. Kärre K, Klein G, Kiessling R, Klein E, Roder J (1980) Low natural in vivo resistance to syngeneic leukemias in natural killer-deficient mice. Nature 284:624–626

    Google Scholar 

  24. Kasai M, Iwamori M, Nagai Y, Okumura K, Tada T (1980) A glycolipid on the surface of mouse natural killer cells. Eur J Immunol 10:175–180

    Google Scholar 

  25. Kiessling R, Wigzell H (1979) An analysis of the murine NK cell as to structure, function, and biological relevance. Immunol Rev 44:165–208

    Google Scholar 

  26. Kiessling R, Klein E, Pross H, Wigzell H (1975) “Natural” killer cells in the mouse. II. Cytotoxic cells with specificity for mouse moloney leukemia cells. Characterics of the killer cell. Eur J Immunol 51:117–121

    Google Scholar 

  27. Liotta L, Vembu D, Saini R, Boone C (1978) In vivo monitoring of the death rate of artificial murine pulmonary micrometastases. Cancer Res 38:1231–1236

    Google Scholar 

  28. Lotze MT, Line BR, Mathisen DJ, Rosenberg SA (1980) The in vivo distribution of autologous human and murine lymphoid cells grown in T cell growth factor (TCGF): implications for the adoptive immunotherapy of tumors. J Immunol 125:1487–1493

    Google Scholar 

  29. Oldham RK, Herberman RB (1973) Evaluation of cell-mediated cytotoxic reactivity against tumor associated antigens with 125I-iododeoxyuridine labeled target cells. J Immunol 111:1862–1871

    Google Scholar 

  30. Pross HF, Jondal M (1975) Cytotoxic lymphocytes from normal donors. A functional marker of human non-T lymphocytes. Clin Exp Immunol 21:226–235

    Google Scholar 

  31. Rannie GH, Thakur ML, Ford WL (1977) An experimental comparison of radioactive labels with potential application to lymphocyte migration studies in patients. Clin Exp Immunol 29:509–514

    Google Scholar 

  32. Riccardi C, Puccetti P, Santoni A, Herberman RB (1979) Rapid in vivo assay of mouse NK cell activity. J Natl Cancer Inst 63:1041–1045

    Google Scholar 

  33. Riccardi C, Santoni A, Barlozzari T, Herberman R (1980a) Role of NK cells in rapid in vivo clearance of radiolabeled tumor cells. In: Herberman R (ed) Natural cell-mediated immunity against tumors, vol 1. Academic Press, New York, pp 1121–1139

    Google Scholar 

  34. Riccardi C, Santoni A, Barlozzari T, Puccetti P, Herberman RB (1980b) In vivo natural reactivity of mice against tumor cells. Int J Cancer 25:475–486

    Google Scholar 

  35. Riccardi C, Barlozzari T, Santoni A, Herberman RB, Cesarini C (1981) Transfer to cyclophosphamide-treated mice of natural killer (NK) cells and in vivo natural reactivity against tumors. J Immunol 126:1284–1289

    Google Scholar 

  36. Rosenberg SA, Schwarz S, Spiess PJ (1978) In vitro growth of murine T cells. II. Growth of in vitro sensitized cells cytotoxic for alloantigens. J Immunol 121:1951–1955

    Google Scholar 

  37. Sjögren HO, Hellström I (1965) Induction of polyoma specific transplantation antigenicity in Moloney leukemia cells. Exp Cell Res 40:208–212

    Google Scholar 

  38. Sparshott SM, Sharma H, Kellog JD, Ford WL (1981) Factors influencing the fate of 111Indium-labeled lymphocytes after transfer to syngeneic rats. J Immunol Methods 41:303–320

    Google Scholar 

  39. Stutman O, Figarella E, Paige C, Lattine E (1980) Natural cytotoxic (NC) cells against solid tumors in mice: general characteristics and comparison to natural killer (NK) cells. In: Herberman R (ed) Natural cell-mediated immunity against tumors, vol 1. Academic Press, New York, pp 187–230

    Google Scholar 

  40. Talmadge J, Meyers K, Prieur D, Starkey J (1980) Role of NK cells in tumor growth and metastasis in beige mice. Nature 284:622–624

    Google Scholar 

  41. Thakur ML, Coleman RE, Welch MJ (1977) Indium-111 labeled leukocytes for the localization of absesses: preparation analysis, tissue distribution and comparison with gallium-67 citrate in dogs. J Lab Clin Med 89:217–228

    Google Scholar 

  42. Waytes T, Bacon L, Rose N (1980) Use of indium-111 in antibody-dependent complement-mediated cytotoxicity assay for detection of B-locus alloantigens on chicken lymphocytes. Transplantation 29:201–205

    Google Scholar 

  43. Wiltrout RH, Frost P (1980) Cell-mediated cytotoxic responses induced in vivo and in vitro by a metastatic murine tumor. J Immunol 124:2254–2263

    Google Scholar 

  44. Wiltrout RH, Frost P, Cummings GD (1978) Isotope-release cytotoxicity assay with the use of indium-111: advantage over chromium-51 in long-term assays. J Natl Cancer Inst 61:183–188

    Google Scholar 

  45. Wiltrout RH, Taramelli D, Holden HT (1981) Measurement of macrophage-mediated cytotoxicity against adherent and non-adherent target cells by release of 111indium-oxine. J Immunol Methods 43:319–331

    Google Scholar 

  46. Young WW Jr, Hakomori S-I, Durdik JM, Henney CS (1980) Identification of ganglio-N-tetraosylceramide as a new cell surface marker for murine natural killer (NK) cells. J Immunol 124:199–201

    Google Scholar 

Download references

Author information

Author notes

  1. M. J. Brunda

    Present address: Department of Immunotherapy, Hoffmann-LaRoche, Inc., Nutley, NJ, USA

Authors and Affiliations

  1. Biological Therapeutics Branch, National Cancer Institute, 21701, Frederick, MD

    R. H. Wiltrout, E. Gorelik, M. J. Brunda, H. T. Holden & R. B. Herberman

Authors
  1. R. H. Wiltrout
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. E. Gorelik
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. M. J. Brunda
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. H. T. Holden
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. R. B. Herberman
    View author publications

    You can also search for this author in PubMed Google Scholar

Additional information

Abbreviations used in this paper are: IV, intravenously; NK, natural killer; [125I]dUrd, 125I-iododeoxyuridine; [111In]Ox, Indium-111-Oxine chelate; 51Cr, chromium-51; CTC, cultivated T cells, i.f.p., intrafootpad

Rights and permissions

Reprints and permissions

About this article

Cite this article

Wiltrout, R.H., Gorelik, E., Brunda, M.J. et al. Assessment of in vivo natural antitumor resistance and lymphocyte. Cancer Immunol Immunother 14, 172–179 (1983). https://doi.org/10.1007/BF00205356

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00205356

Keywords

Search

Navigation